Arkema navigates the Middle East shock with pricing discipline and portfolio diversity
Q1 2026 confirms resilient specialty volumes, but the conflict-driven input cost spiral is the new battleground.
AKE.PA · Earnings Call · 2026-05-06
## A conflict-driven reset
Arkema's Q1 2026 was a tale of two forces: stable specialty volumes and a fresh wave of input cost inflation triggered by the Middle East conflict that erupted in late February. The company delivered EUR 283 million EBITDA, down year-on-year but slightly above expectations, thanks to a March pickup. As Thierry Le Hénaff noted, “End of February saw the outbreak of the conflict in the Middle East, which started to impact global supply chains and quickly led to a sharp rise in certain raw materials as well as in energy and logistics costs beginning in Asia.” — Thierry Le Hénaff, Chairman and Chief Executive Officer · 2026-05-06 The financials show resilience: “Q1 EBITDA came in at EUR 283 million. The currency effect represented a negative of around EUR 20 million.” — Marie-José Donsion, Chief Financial Officer · 2026-05-06 The real story is not the quarter but the battle ahead.
## A new cost paradigm
The conflict has upended the cost curve. “You have increased on raw materials, which can run from a few percent to 100%.” — Thierry Le Hénaff, Chairman and Chief Executive Officer · 2026-05-06 Arkema's teams, trained by COVID, are moving fast to pass through pricing, but input cost inflation is now the dominant theme. Thierry acknowledged the time lag, particularly for downstream businesses, and the company is relying on its portfolio diversity to offset the squeeze. The theme of sulfur is emblematic: a mid-stream supply shock that hits Performance Additives hardest.
The company's stance is carefully balanced: That neutrality is a bold claim in a volatile environment, but it echoes the prepared remarks about a balanced geographical footprint and a product mix that can benefit from tight supply-demand in certain value chains. ## Portfolio as a shock absorber The conflict highlights the value of diversification. While Advanced Materials had a sluggish start, Coating Solutions improved margins by 100bps on mix, and Primary Materials were lifted by legacy refrigerants. The company kept volumes stable overall, and Specialty Materials grew 1.5%, driven by energy storage systems and other high-growth pockets that rose 15%. This contrasts with prior quarters where destocking and demand weakness were the main concerns. Back in February, Thierry was still talking about low inventory levels: “It's clear that the stock for most of the chain seems to be rather low, but they are low if there is a rebound...” — Thierry Le Hénaff · 2026-02-26 The narrative has shifted from a demand problem to a cost problem. ## Growth pockets intact Despite the headwinds, Arkema is investing through the cycle: the new PVDF capacity in the U.S. starts mid-year, and Rilsan Clear in Singapore is ramping up. The company reiterated its 2026 target of slight EBITDA growth at constant exchange rates. This forward positioning is a contrast to the low-cycle pessimism of late 2025, when Thierry conceded: “I think clearly, we are in a low cycle. So where are we exactly? I think everybody has to be modest on that.” — Thierry Le Hénaff, Chairman and Chief Executive Officer · 2025-11-07 Now the company is more confident about managing the shock. The global market is also watching the same theme — Middle East conflict is among the top momentum keywords for 20262, and several peers (ADNT, GPN) flagged similar supply chain disruptions. Arkema's ability to hold guidance while peers trim is a differentiator. But the real test will be whether the neutrality thesis holds. The raw material surge is fast and steep, and the company is betting on timely pricing actions and portfolio hedging. The next quarters will show if the balance holds.I said that I believe that this crisis will have a positive and negative impacts. But all in all, for Arkema, it should be around neutral.